Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

A Comparison of Two Intensive Walking Training Interventions in Community Dwelling Individuals With History of Stroke

23 settembre 2011 aggiornato da: Vince DePaul, McMaster University

A Motor Learning Based Walking Program Versus Body Weight Supported Treadmill Training in Community Dwelling Adults Within One Year of Stroke Onset: A Randomized Controlled Trial

Stroke is a major cause of disability in Canadian adults. Following a stroke, many people have difficulty walking in their home and in the community. The purpose of this study is to compare the effect of two different approaches to walking retraining in people who have had a stroke.

Individuals living in the community who have had recently had a stroke will be asked to participate in this study. Participants will be randomly assigned to one of two five week walking training programs. In one program, individuals will re-learn to walk in a variety of real-life situations. Practice sessions will encourage active problem solving by the participants. The other program will have participants practice walking on a treadmill while some of their body weight is supported by a special harness system. Participants will also be assisted by a physiotherapist to walk in a more normal manner.

Participants' will be assessed at the beginning of the study, after the 5 week training program and again, eight weeks later. The research assistant will assess their ability to walk, their confidence level and the average daily walking activity.

Primary Hypothesis: Individuals assigned to the Motor Learning Walking Program will improve their walking ability from baseline to follow up assessment significantly more than individuals assigned to the Treadmill Training Program.

The results of this study will help physiotherapists plan effective treatment programs for individuals with walking difficulties following stroke. It will also give researchers direction for future studies in the areas of walking retraining and motor skill development post-stroke.

Panoramica dello studio

Tipo di studio

Interventistico

Iscrizione (Effettivo)

71

Fase

  • Fase 2

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Luoghi di studio

    • Ontario
      • Hamilton, Ontario, Canada, L8N 4A6
        • St. Joseph's Healthcare Hamilton

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

40 anni e precedenti (Adulto, Adulto più anziano)

Accetta volontari sani

No

Sessi ammissibili allo studio

Tutto

Descrizione

Inclusion Criteria:

  • Stroke onset within previous 12 months
  • Age 40 or older
  • Able to follow 2 step verbal command (English),
  • Able to walk 10 metres without human assistance (may use walking aid)
  • Independent community ambulatory prior to stroke
  • Community dwelling
  • Approval from physician for participation in study

Exclusion Criteria:

  • Walking speed greater than 1.0 m/s without walking aid
  • Within normal limits on Modified Mini Mental Status test (age and education adjusted)
  • Documented global aphasia
  • Legal blindness
  • Unable to exercise due to the any of the following conditions
  • A recent significant change in resting ECG suggesting ischemia
  • Recent Myocardial infarction (within 3 months) or other acute cardiac event
  • Unstable angina
  • Severe SOB at rest or with activities of daily living
  • Uncontrolled cardiac arrhythmias causing symptoms
  • Severe symptomatic aortic stenosis
  • Uncontrolled symptomatic heart failure
  • Acute pulmonary embolus or pulmonary infarction
  • Acute myocarditis or pericarditis
  • Suspected or known dissecting aneurysm
  • Acute systemic infection, accompanied by fever, body ache or swollen lymph glands
  • Uncontrolled hypertension (systolic > 200 mmHg, diastolic > 110 mmHg )
  • Severe peripheral vascular disease with sustained claudication (resulting in limited walking tolerance)
  • Severe lower extremity orthopedic problems with severe pain on weight bearing
  • Lower extremity amputation that requires prosthesis

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Trattamento
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Separare

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: Motor Learning Walking Program
Motor Learning principles based Walking Program (MLWP) Participants practice variety of real life over ground walking related activities. Order of practice, instructions, guidance and feedback are provided in a manner that facilitates cognitive engagement of learner.
Motor Learning principles based Walking Program (MLWP) Participants practice variety of real life over ground walking related activities. Order of practice, instructions, guidance and feedback are provided in a manner that facilitates cognitive engagement of learner. Sessions 45 minutes, 3x per week over 5 weeks for a total of 15 sessions
Altri nomi:
  • Task oriented walking training
Comparatore attivo: Body weight supported treadmill training
Body Weight Supported Treadmill Training. Participants walk on a treadmill while partially supported with an overhead harness system. Mass repetition of the normal gait cycle is encouraged through the support of the harness, the movement of the treadmill, and the assistance of one or two trainers to position limbs and trunk.
Participants practice walking on a treadmill while supported with an overhead harness system. Up to 40% body weight support. Target Treadmill speed 2.0 mph. 1 or 2 Trainers (at least one Physical Therapist plus another Physical Therapist or Physiotherapy Assistant) will help guide participants leg, foot and trunk during treatment. Aim is to practice high numbers of repetition of the normal gait cycle on treadmill. Duration of sessions - 20 minutes of treadmill training within a 45 minute session ( 4 sets of 5 minutes of training with 5 minute rests). 3 sessions per week for 5 weeks. Total of 15 sessions.
Altri nomi:
  • Allenamento su tapis roulant

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Lasso di tempo
Self selected over ground gait speed - 5 metre walk test
Lasso di tempo: 8 week follow up
8 week follow up

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Six Minute Walk Test
Lasso di tempo: Post Intervention and 8 week follow up
Post Intervention and 8 week follow up
Self selected over ground gait speed - 5 metre walk test
Lasso di tempo: Post Intervention
Post Intervention
Balance related Self Efficacy - Activities-specific Balance Confidence Scale
Lasso di tempo: Post intervention and 8 week follow up
Post intervention and 8 week follow up
Average Daily Step Count - StepWatch 3 Step Activity Monitor
Lasso di tempo: Post Intervention and 8 Week Follow up
Post Intervention and 8 Week Follow up
Dynamic Balance - Functional Balance Test
Lasso di tempo: Baseline, Post-intervention and 8 week Follow-up

Over a 9 m track - participants are required to perform 5 balance and walking related tasks. Participants are required to 1) rise from a chair, walk 3 m, 2) step up and down an 8 inch step, walk 3 m, 3) bend down to pick up and return a 2.5 kilo weight off floor, walk 3 m to marked spot on the floor, 4) turn 180 degrees and walk 9 m back to the chair, 5. sit back down in the chair.

Each task is scored on a 4 point scale (total score of out 20) Participants are timed on how long it takes them to perform the entire circuit.

Baseline, Post-intervention and 8 week Follow-up
Life Space Questionnaire
Lasso di tempo: Baseline, Post-intervention, and at 8 week follow up
Self-report measure of mobility partipation.
Baseline, Post-intervention, and at 8 week follow up
Number of trainers required per treatment session
Lasso di tempo: Documented at every treatment session for both experimental and active comparison interventions.
Documented at every treatment session for both experimental and active comparison interventions.
Patient Specific Functional Scale
Lasso di tempo: Baseline, Post-intervention, Follow-up (8weeks)

In this measure, participants are asked to identify 3 walking related functional activities that they currently have some difficulty performing and would like to improve with treatment. For each activity, the participant rates their current ability to perform the task on a numeric rating scale of 0 to 10.

At Post-intervention and Follow-up, participants re-rate their current ability on the same activites (without seeing their previous score).

Baseline, Post-intervention, Follow-up (8weeks)
Rating of Walking functional level - Modified Functional Walking Categories
Lasso di tempo: Baseline, Post-intervention, Follow-up (8 weeks)
Baseline, Post-intervention, Follow-up (8 weeks)
Adverse event - Self-report of a fall(s) since baseline assessment
Lasso di tempo: Post Intervention Assessment
Participants will be asked whether or not they have had a fall since baseline assessment. Details of the fall(s) will be recorded. Fall report based on participant recall - no other tools (e.g. diary) will be used.
Post Intervention Assessment
Adverse event - Falls (yes or no)
Lasso di tempo: Follow - up - 8 weeks after post-intervention assessment

Participant asked to report whether or not they had a fall since Post Intervention assessment. Details of the fall will be provided.

Based on participant recall - no other tools for falls recording will be used (ie. will not be using falls diary)

Follow - up - 8 weeks after post-intervention assessment
Serious adverse events - ie. new stroke, myocardial infarction, overnight hospital admission, death
Lasso di tempo: Post-intervention, Follow up (8 weeks)
Serious adverse events will be based on participant or caregiver report, and confirmed with primary care physician as appropriate.
Post-intervention, Follow up (8 weeks)

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Investigatori

  • Investigatore principale: Vincent G DePaul, PhD (c), McMaster University, Hamilton, ON, Canada

Pubblicazioni e link utili

La persona responsabile dell'inserimento delle informazioni sullo studio fornisce volontariamente queste pubblicazioni. Questi possono riguardare qualsiasi cosa relativa allo studio.

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio

1 dicembre 2006

Completamento primario (Effettivo)

1 gennaio 2011

Completamento dello studio (Effettivo)

1 giugno 2011

Date di iscrizione allo studio

Primo inviato

20 novembre 2007

Primo inviato che soddisfa i criteri di controllo qualità

20 novembre 2007

Primo Inserito (Stima)

21 novembre 2007

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Stima)

26 settembre 2011

Ultimo aggiornamento inviato che soddisfa i criteri QC

23 settembre 2011

Ultimo verificato

1 settembre 2011

Maggiori informazioni

Termini relativi a questo studio

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi